AC Immune SA (ACIU)

Key Insights

• The CEO of AC Immune SA, Andrea Pfeifer, has purchased 10,000 shares of the company's stock at an average price of $3.1425 per share, indicating confidence in the company's future performance.
• Pfeifer's total beneficial ownership has increased to 3,830,288 shares, including 1,921,005 shares underlying restricted share units, suggesting a significant stake in the company.
• The transaction was executed pursuant to a trading plan, which may indicate a pre-planned strategy for insider buying and could signal positive long-term expectations for the stock.